Bruker (BRKR) Tops Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Bruker Reports Fourth Quarter and Fiscal Year 2020 Financial Results
February 16, 2021 7:00 AM ESTQ4 2020 revenues up 4.6% year-over-year; organic revenue declines 0.4% Q4 2020 GAAP EPS of $0.45; non-GAAP EPS of $0.58 Expanded Project Accelerate 2.0 in proteomics, spatial biology and molecular diagnostics Strong revenue growth, Non-GAAP margin expansion and EPS growth expected in FY 2021
BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) today announced... More
